期刊文献+

系统性真菌感染的药物治疗进展 被引量:10

DeveIopments of Antifungal Agents in the Treatment of Systemic Fungal Infection(a review)
下载PDF
导出
摘要 随着系统性真菌感染的发病率急剧上升,寻找新型抗真菌药物,特别是对耐唑类菌株有效的药物研究已成为临床治疗系统性真菌感染的迫切需要。本文分类综述近年来临床常用的以及最新研究开发的抗真菌药物,为临床治疗系统性真菌感染提供新的选择。 Due to With the increasing incidence of systemic fungal infection,the searching for new antifungal agents,especially resistant - strain compounds, has been focal point, in the treatment of systemic fungal infection, Recent researches and developments of antifungal agents were reviewed.
作者 周汛 李桂明
出处 《皮肤病与性病》 2006年第1期17-20,共4页 Dermatology and Venereology
关键词 系统性真菌感染 新型抗真菌药物 综述 治疗 systemic fungal infection antifungal agents review tratment
  • 相关文献

参考文献26

  • 1Hossain MA.Maesaki S,Kakeya H,et al.Efficacy of NS -718,anovellipidnanosphere-encapsulated AmphotericinB,against Crytococcusneoformans[J].AntimicrobAg Chemother,1998,42 (7):172 2-1725.
  • 2Johason EM,Ojwang JO,Szekely A,et al.Comparisonofvitro antifungalac tivieso ffreeandlip osome -encap sulated Ny statin Withthoseoffour Amphotericin B for mulations[J].AntimicorAg Chemot her,1998,42 (6):1412-1416.
  • 3施志欣,唐琳,白桦,蒋笑平.氟康唑治疗阴道念珠菌病[J].新药与临床,1997,16(4):226-227. 被引量:6
  • 4王昆润摘.氟康唑治疗有食道损害的慢性复发性念珠菌病[J].国外医学:药学分册,1997,24(1):50-51.
  • 5Menon T,Umamaheswari K,Kumrasamy N,et al.Efficacy of fluconazole and itraconazole in the treatment of oral candiasis in HIVpatients[J],Acta Tropica,2001,80(1):151-154.
  • 6Morgenstern G R,Prentice HG,et al.Arandomized controlled trial of itraconazole Versus fluconazole for the prevention of fungal infectionsin patients with haematological malignancies[J].U.K.Multicentre Antifungal Prophylaxis study Group.
  • 7周琼.抗真菌药物与其他药物的相互作用及机制[J].医药导报,2002,21(S1):76-77. 被引量:5
  • 8Prentice H G,Caillot D,Dupont B,et al.Oral and intravenous itraconazole for systemic fungal infections in neutropenic haematologi cal patients[J].Meeting report.London,United Kingdom,20June,1998.Acta haematol,1999,101 (1):56-62.
  • 9Kapsi S G Ayres J W.Processing factors in development of solid solution formulation of itraconazole for enharcement of drugdissoluton and bioavailability[J].Inter J Pharmaceutis,2001,229:193-203.
  • 10Menichetti F,De Favero A,MartinO P,et al.Itraconazole oral solution as prophylaxis for fungal infections in neutropenic patients with haematologic malignancies:a vandomized,plagebo-controlled,doubled-blind,multicenter trial[J].Clin infectdis,1999,28:250-255.

二级参考文献6

  • 1陆一瓴,黄嘉鑫,张鸿龙.含L-4-氧代赖氨酸寡肽的合成及其抗白念珠菌活性[J]药学学报,1988(07).
  • 2Brodell R T,Elewski B E.Clinical peart: systenic antifungal drugs and drug interactions[].Journal of the American Academy of Dermatology.1995
  • 3Bicker D R.Antifungal therapy: potential interactions with other classes drugs[].Journal of the American Academy of Dermatology.1994
  • 4Gupta A K,Sauder D N,Shear N H.Antifungal agent: an overview part 1[].Journal of the American Academy of Dermatology.1996
  • 5Gupta A K,Sauder D N,Shear N H.Antifungal agents: an overview part 1[].Journal of the American Academy of Dermatology.1996
  • 6Jacob P H,Nall L.Systemic antifungals[].Cutis.1993

共引文献23

同被引文献78

引证文献10

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部